Biogen Inc. Common Stock (NASDAQ: BIIB) last traded at $216.78, up 1.13% on the session. The quote above updates while this page is open; the figures below are drawn from Biogen Inc. Common Stock’s own filings and are restated only when a new one is published.
Biogen Inc. Common Stock trades on NASDAQ under the ticker BIIB. Its market capitalisation is $32.00 billion.
Valuation measures for Biogen Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $32.00B |
|---|---|
| P/E ratio | 23.31 |
| Price / sales | 3.22 |
| Beta | 0.28 |
Trailing-twelve-month figures tagged in Biogen Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $9.94B |
|---|---|
| Net income (TTM) | $1.37B |
| EPS (TTM) | $9.30 |
Range and volume for BIIB over the past 52 weeks.
| 52-week high | $222.15 |
|---|---|
| 52-week low | $131.52 |
| Volume | 695.5K |
| Average volume | 1.17M |
| Previous close | $214.35 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.